GL1X · GenesisL1 explorer

Research workbench

Structure of SARS-cov-2 spike receptor-binding domain Y453F mutation complexed with american mink ACE2

Analyse Structure of SARS-cov-2 spike receptor-binding domain Y453F mutation complexed… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7W8S
Type
protein
Length
788 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensin-converting enzyme 2; Spike protein S1
UniProt
P0DTC2
Ligands
NAG, ZN
Pockets
9 · best druggability 0.76

Structure

electron microscopy · 2 distinct chains · 45% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiotensin-converting enzyme 2protein59556% helix, 3% strand—
BSpike protein S1protein19311% helix, 25% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
  • ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1960.760.9722empty
210940.730.76109empty
35380.680.7852empty
4710.490.8314empty
5820.480.8215empty

Interfaces

1 interface between chains.

  • A–B · 976 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7W8S · Structure of SARS-CoV-2 spike receptor-binding domain Y453F mutation complexed with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.